Imatinib Mesylate from Canada
Imatinib mesylate, tyrosine kinase inhibitor with pyrimidine and piperazine rings (N hetero-atoms only), used in leukemia treatment. HTS 2933.99.8290 for bulk API as other aromatic heterocyclic nitrogen compounds. Key oncology pharmaceutical intermediate.
Duty Rate — Canada → United States
16.5%
Rate breakdown
9903.05.2910%Section 301 (forced labor) — additional 10% ad valorem on products of Canada
Import Tips
• Include DEA import permit if precursor status applies
• Specify crystalline form (polymorph B typically) in COA
• Provide stability data for transport conditions